# tDCS Plus Varenicline for Smoking Cessation

> **NCT06798324** · PHASE4 · RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 160 (estimated)

## Conditions studied

- Nicotine Dependence
- Tobacco Smoking
- Smoking Cessation
- Nicotine Use Disorder
- Tobacco Use Disorder
- Substance Use Disorders

## Interventions

- **DEVICE:** Active Transcranial Direct Current Stimulation (tDCS)
- **DRUG:** Varenicline 1mg BID
- **DEVICE:** Sham Transcranial Direct Current Stimulation (tDCS)

## Key facts

- **NCT ID:** NCT06798324
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2028-01-20
- **Final completion:** 2028-08-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798324, "tDCS Plus Varenicline for Smoking Cessation". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06798324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*